FDA Approved: OXYCODONE AND ACETAMINOPHEN — Supplemental Application (Granules Pharmaceuticals Inc.)

View source ↗

Summary

FDA approves Granules Pharmaceuticals Inc.'s supplemental application to market a generic oxycodone/acetaminophen product (ANDA 211708).

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Pain

Drugs mentioned

• OXYCODONE AND ACETAMINOPHEN (oxycodone and acetaminophen)

Snippet

SUPPL AP for OXYCODONE AND ACETAMINOPHEN (OXYCODONE AND ACETAMINOPHEN)